Fig. 2
From: Targeting pathogenic fibroblast-like synoviocyte subsets in rheumatoid arthritis
CDH-11, FAPα, PDPN, CD90 and CD248 are relatively specific synovial FLS markers. Targeting pathogenic FLS surface markers with specific antibodies, inhibitors, vaccines or CART cell might be potential strategies for the treatment of RA